{
  "id": 6876,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Debate"
    },
    "dialogue_turns": [
      {
        "speaker": "A",
        "text": "...just eighteen days, I mean, think about that! Eighteen days to find six promising treatments. That's, uh, revolutionary.",
        "tts_text": "...just eighteen days, I mean, think about that! Eighteen days to find six promising treatments. That's, uh, revolutionary.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "That system, called generative tensorial reinforcement learning, or GENTRL for short, was able to find six promising treatments in just 21 days, one of which showed promising results in an experiment involving mice.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "B",
        "text": "Revolutionary? Come on, A, that's a huge stretch. It's eighteen days to identify them, not, like, get them on the market. But B, the article clearly states it took forty-three days for design, synthesis, and validation. And for, what, 150 grand? Compared to seven years and millions for the traditional method?",
        "tts_text": "Revolutionary? Come on, A, that's a huge stretch. It's eighteen days to identify them, not, like, get them on the market. But B, the article clearly states it took forty-three days for design, synthesis, and validation. And for, what, one hundred fifty grand? Compared to seven years and millions for the traditional method?",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "It took about 21 days for the AI system to design molecules, and the total time for design, synthesis and validation was about 46 days. ... The challenge was based on recently published research from a team at Genentech, which had taken about 8 years to identify promising DDR1 kinase inhibitors.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "A",
        "text": "Okay, sure, initial identification. But then it says, and I quote, 'None of the drugs designed by GENTRL appear to be more effective than inhibitors developed using the traditional research method.'",
        "tts_text": "Okay, sure, initial identification. But then it says, and I quote, 'None of the drugs designed by G E N T R L appear to be more effective than inhibitors developed using the traditional research method.'",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Although none of the drugs designed by GENTRL would appear to be more effective than inhibitors developed by the traditional research method, the traditional process to develop drug candidates took over 8 years and millions of dollars to develop - compared to the handful of weeks and approximate $150,000 cost of Insilicos method.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "B",
        "text": "But that's not the point! The point is the speed and the cost. You can iterate so much faster! Like, Zhavoronkov even says their molecules are 'amazing' and 'very close to being state-of-the-art.'",
        "tts_text": "But that's not the point! The point is the speed and the cost. You can iterate so much faster! Like, Zhavoronkov even says their molecules are 'amazing' and 'very close to being state-of-the-art.'",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Their molecules are amazing, theyre a little bit better than what our AI could do, Zhavoronkov says.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "A",
        "text": "Yeah, 'very close' isn't 'better.' And he also says this is 'just the initial step' and it'll take 'years of clinical trials and millions spent.' You're glossing over the crucial bits.",
        "tts_text": "Yeah, 'very close' isn't 'better.' And he also says this is 'just the initial step' and it'll take 'years of clinical trials and millions spent.' You're glossing over the crucial bits.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Of course, in the grand scheme of drug development, this only represents the very first step. While this represents a milestone in demonstrating the potential of AI to identify drug candidates, it will still take years of clinical trials and millions spent on investigation before any drug candidate is approved for use to treat a particular disease.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "B",
        "text": "No, I'm just looking at the bigger picture! This brings down skepticism for big pharma, like, it changes the entire paradigm of drug discovery.",
        "tts_text": "No, I'm just looking at the bigger picture! This brings down skepticism for big pharma, like, it changes the entire paradigm of drug discovery.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "I think that this paper will remove a lot of skepticism in big pharma, he says.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "A",
        "text": "Does it, though? It's a nice proof-of-concept, I guess. But if the end result isn't better, then what's the real advantage beyond some efficiency gains at the very, very beginning?",
        "tts_text": "Does it, though? It's a nice proof-of-concept, I guess. But if the end result isn't better, then what's the real advantage beyond some efficiency gains at the very, very beginning?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "B",
        "text": "The advantage is that efficiency! You can explore so many more avenues. Think about all the diseases that don't get funding because traditional drug discovery is just too slow and expensive.",
        "tts_text": "The advantage is that efficiency! You can explore so many more avenues. Think about all the diseases that don't get funding because traditional drug discovery is just too slow and expensive.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "A",
        "text": "But you're still stuck with the clinical trials, aren't you? That's the bottleneck, not necessarily the initial identification. They still have to prove it's safe and effective in humans, which takes years and billions.",
        "tts_text": "But you're still stuck with the clinical trials, aren't you? That's the bottleneck, not necessarily the initial identification. They still have to prove it's safe and effective in humans, which takes years and billions.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "While this represents a milestone in demonstrating the potential of AI to identify drug candidates, it will still take years of clinical trials and millions spent on investigation before any drug candidate is approved for use to treat a particular disease.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "B",
        "text": "Right, but imagine if you could cut down the pipeline of potential drugs from, like, a trickle to a gushing river! You're focusing on the last mile, I'm talking about the whole damn marathon!",
        "tts_text": "Right, but imagine if you could cut down the pipeline of potential drugs from, like, a trickle to a gushing river! You're focusing on the last mile, I'm talking about the whole damn marathon!",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "A",
        "text": "No, I'm focusing on the finish line, which this AI hasn't even sniffed yet. It's a cool tool, A, but it's not the silver bullet you're making it out to be. It's, um, like a fancy new shovel, not a whole new construction method.",
        "tts_text": "No, I'm focusing on the finish line, which this A I hasn't even sniffed yet. It's a cool tool, A, but it's not the silver bullet you're making it out to be. It's, um, like a fancy new shovel, not a whole new construction method.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "B",
        "text": "A fancy new shovel that finds gold where no one else could even dig! This is going to fundamentally change things. Zhavoronkov himself compares it to AlphaGo! That's huge.",
        "tts_text": "A fancy new shovel that finds gold where no one else could even dig! This is going to fundamentally change things. Zhavoronkov himself compares it to AlphaGo! That's huge.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Weve got AI strategy combined with AI imagination, says Insilico CEO Alex Zhavoronkov, who compares the operation of GENTRL to the AlphaGo machine learning system that Googles Deepmind developed to challenge champion Go players.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "A",
        "text": "AlphaGo played a game. This is, like, human health. The stakes are a little higher, don't you think? And, uh, it's not even delivering better drugs yet.",
        "tts_text": "AlphaGo played a game. This is, like, human health. The stakes are a little higher, don't you think? And, uh, it's not even delivering better drugs yet.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Although none of the drugs designed by GENTRL would appear to be more effective than inhibitors developed by the traditional research method...",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "B",
        "text": "But it will, B! It's just getting started. This is the first step, obviously. You're being, like, ridiculously pessimistic about a massive breakthrough.",
        "tts_text": "But it will, B! It's just getting started. This is the first step, obviously. You're being, like, ridiculously pessimistic about a massive breakthrough.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "A",
        "text": "And you're being ridiculously optimistic about something that's barely left the lab, and already has huge caveats. It's, um, a long way from the hospital bed.",
        "tts_text": "And you're being ridiculously optimistic about something that's barely left the lab, and already has huge caveats. It's, um, a long way from the hospital bed.",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      }
    ]
  },
  "batch_index": 3
}